Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Pharmacyclics LLC v. Hetero USA Inc., 19-0014 (D. Del.) Jan. 4, 2019 Hon. Colm F. Connolly Imbruvica® (ibrutinib capsules) 10,106,548
Valeant Pharms. North America LLC v. Strides Pharma Inc., 19-0133 (D.N.J.) Jan. 4, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Celgene Corp. v. Aurobindo Pharma Ltd., 19-0143 (D.N.J.) Jan. 4, 2019 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 9,993,467
Arbor Pharms., LLC v. Teva Pharms. USA, Inc., 19-0053 (D. Del.) Jan. 9, 2019 Hon. Colm F. Connolly Sklice® (ivermectin lotion) 8,791,153
8,927,595
Bristol-Myers Squibb Co. v. Unichem Labs., Ltd., 19-0055 (D. Del.) Jan. 9, 2019 Hon. Leonard P. Stark Eliquis® (apixaban tablets) 6,967,208
Sun Pharm. Indus. Ltd. v. Novartis Pharms. Corp., 19-0276 (D.N.J.) Jan. 9, 2019 Hon. Susan D. Wigenton Jadenu® (deferasirox tablets) 9,283,209
Moderna Therapeutics, Inc. v. Arbutus Biopharma Corp., IPR2019-00554 (PTAB) Jan. 9, 2019 N/A Onpattro® (patisiran sodium for injection) 8,058,069
Onyx Therapeutics, Inc. v. Breckenridge Pharm., Inc., 19-0071 (D. Del.) Jan. 11, 2019 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,417,042
7,737,112
8,207,125
Genentech, Inc. v. Laurus Labs Ltd., 19-0078 (D. Del.) Jan. 14, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
7,696,236
7,767,225
7,988,994
8,753,679
Gilead Sciences, Inc. v. Zydus Pharms. (USA) Inc., 19-0529 (D.N.J.) Jan. 15, 2019 Hon. Brian R. Martinotti Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets) 6,642,245
6,703,396
8,592,397
8,716,264
9,457,036
9,744,181
Genentech, Inc. v. Aurobindo Pharma Ltd., 19-0103 (D. Del.) Jan. 17, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
7,696,236
7,767,225
7,988,994
8,753,679
Genentech, Inc. v. Laurus Labs Ltd., 19-0104 (D. Del.) Jan. 17, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Genentech, Inc. v. Aurobindo Pharma Ltd., 19-0105 (D. Del.) Jan. 17, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
9,561,217
Beloteca, Inc. v. Apicore US LLC, 19-0360 (N.D. Ill.) Jan. 17, 2019 Hon. John J. Tharp, Jr. Lymphazurin® (isosulfan blue for injection) 7,662,992
8,969,616
9,353,050
Genentech, Inc. v. Lupin Ltd., 19-0109 (D. Del.) Jan. 18, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
7,696,236
7,767,225
7,988,994
8,753,679
Genentech, Inc. v. Lupin Ltd., 19-0110 (D. Del.) Jan. 18, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Genentech, Inc. v. Micro Labs Ltd., 19-0111 (D. Del.) Jan. 18, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Genentech, Inc. v. Apotex Inc., 19-0120 (D. Del.) Jan. 22, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
7,696,236
7,767,225
7,988,994
8,753,679
Genentech, Inc. v. Apotex Inc., 19-0123 (D. Del.) Jan. 22, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
9,561,217
Par Pharm., Inc. v. Pfizer Inc., 19-0615 (S.D.N.Y.) Jan. 22, 2019 Hon. William H. Pauley, III Chantix® (varenicline tartrate tablets) 6,890,927
7,265,119
Genentech, Inc. v. Shilpa Medicare Ltd., 19-0130 (D. Del.) Jan. 23, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 8,383,150
8,778,947
Genentech, Inc. v. SciGen Pharms. Inc., 19-0131 (D. Del.) Jan. 23, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 8,383,150
9,561,217
Genentech, Inc. v. SciGen Pharms. Inc., 19-0132 (D. Del.) Jan. 23, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 8,383,150
8,420,674
7,767,225
7,988,994
8,753,679
Valeant Pharms. North America LLC v. Cipla Ltd., 19-0988 (D.N.J.) Jan. 23, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Valeant Pharms. North America LLC v. Teva Pharms. USA, Inc., 19-0990 (D.N.J.) Jan. 23, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Genentech, Inc. v. Teva Pharms. USA, Inc., 19-0136 (D. Del.) Jan. 24, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Taro Pharm. Indus. Ltd. v. Novitium Pharma, LLC, 19-1028 (D.N.J.) Jan. 24, 2019 Hon. Freda L. Wolfson Ovide® (malathion lotion) 7,560,445
7,977,324
Japan Tobacco Inc. v. Mylan Pharms. Inc., 19-0012 (N.D.W.V.) Jan. 24, 2019 Hon. Irene M. Keeley Stribild® (elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil fumarate tablets) 8,633,219
Genentech, Inc. v. Accord Healthcare, Inc., 19-0141 (D. Del.) Jan. 25, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
7,696,236
7,767,225
7,988,994
8,753,679
Genentech, Inc. v. Accord Healthcare, Inc., 19-0142 (D. Del.) Jan. 25, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Pharmacyclics LLC v. Zydus Worldwide DMCC, 19-0143 (D. Del.) Jan. 25, 2019 Hon. Colm F. Connolly Imbruvica® (ibrutinib capsules) 7,514,444
8,008,309
8,697,711
8,735,403
8,957,079
9,181,257
8,754,091
8,497,277
8,952,015
8,476,284
8,754,090
9,296,753
9,725,455
10,125,140
10,106,548
Genentech, Inc. v. Macleods Pharms. Ltd., 19-0154 (D. Del.) Jan. 28, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
7,696,236
7,767,225
7,988,994
8,753,679
Genentech, Inc. v. Granules Pharms., Inc., 19-0164 (D. Del.) Jan. 28, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 8,383,150
8,420,674
8,778,947
Genentech, Inc. v. Alembic Pharms., Ltd., 19-0177 (D. Del.) Jan. 29, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Genentech, Inc. v. Hetero Labs Ltd., 19-0178 (D. Del.) Jan. 29, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Genentech, Inc. v. Amneal Pharms. LLC, 19-0190 (D. Del.) Jan. 30, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Genentech, Inc. v. Amneal Pharms. LLC, 19-0195 (D. Del.) Jan. 30, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
7,696,236
7,767,225
7,988,994
8,753,679
Galephar Pharm. Research, Inc. v. Upsher-Smith Labs., LLC, 19-2546 (D.N.J.) Jan. 30, 2019 Hon. Madeline Cox Arleo Absorica® (isotretinoin capsules) 7,435,427
8,367,102
8,952,064
9,078,925
9,089,534
Genentech, Inc. v. Sandoz, Inc., 19-0202 (D. Del.) Jan. 31, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
9,561,217
Genentech, Inc. v. Sandoz, Inc., 19-0203 (D. Del.) Jan. 31, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone capsules) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
7,696,236
7,767,225
7,988,994
8,753,679
Genentech, Inc. v. MSN Labs. Private Ltd., 19-0205 (D. Del.) Jan. 31, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 8,383,150
8,778,947
Biogen Int’l GmbH v. Hetero USA Inc., 19-0211 (D. Del.) Jan. 31, 2019 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 7,619,001
Genentech, Inc. v. Cipla Ltd., 19-0219 (D. Del.) Feb. 1, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Keryx Biopharmaceuticals, Inc. v. Chemo Research S.L., 19-0220 (D. Del.) Feb. 1, 2019 Hon. Leonard P. Stark Auryxia® (ferric citrate tablets) 5,753,706
7,767,851
8,093,423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,328,133
9,387,191
9,757,416
Leo Pharma A/S v. Taro Pharms. U.S.A., 19-0221 (D. Del.) Feb. 1, 2019 Hon. Colm F. Connolly Finacea® (azelaic acid foam) 7,700,076
8,435,498
8,722,021
8,900,554
9,211,259
9,265,725
10,117,812
Genentech, Inc. v. Aizant Drug Research Solutions Pvt. Ltd., 19-0223 (D. Del.) Feb. 1, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 7,566,729
7,635,707
7,767,700
7,816,383
7,910,610
8,013,002
8,084,475
8,318,780
8,383,150
8,420,674
8,592,462
8,609,701
8,648,098
8,754,109
8,778,947
Par Pharm., Inc. v. Merck Sharp & Dohme Corp., 19-4432 (D.N.J.) Feb. 1, 2019 Hon. Madeline Cox Arleo Janumet® XR (sitagliptin phosphate / metformin HCl extended-release tablets) 7,326,708
Leo Pharma A/S v. Taro Pharms. U.S.A., 19-1051 (S.D.N.Y.) Feb. 4, 2019 Hon. Colleen McMahon Finacea® (azelaic acid foam) 7,700,076
8,435,498
8,722,021
8,900,554
9,211,259
9,265,725
10,117,812
Genzyme Corp. v. Zenara Pharma Private Ltd., 19-0264 (D. Del.) Feb. 7, 2019 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 6,916,802
7,196,205
7,253,185
7,615,573
Corcept Therapeutics Inc. v. Teva Pharms. USA, Inc., 19-5066 (D.N.J.) Feb. 8, 2019 Hon. Susan D. Wigenton Korlym® (mifepristone tablets) 10,166,242
10,166,243
10,195,214
Genzyme Corp. v. Zenara Pharma Private Ltd., 19-5160 (D.N.J.) Feb. 8, 2019 Hon. Brian R. Martinotti Cerdelga® (eliglustat capsules) 6,916,802
7,196,205
7,253,185
7,615,573
Valeant Pharms. North America LLC v. Zydus Pharms. (USA) Inc., 19-5162 (D.N.J.) Feb. 8, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Biogen Int’l GmbH v. Accord Healthcare Inc., 19-0303 (D. Del.) Feb. 12, 2019 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules) 7,619,001
Meda Pharms. Inc. v. Aurobindo Pharma Ltd., 19-5501 (D.N.J.) Feb. 12, 2019 Hon. Brian R. Martinotti Astepro® (azelastine HCl nasal spray) 8,071,073
8,518,919
9,919,050
Merck Sharp & Dohme Corp. v. Alvogen Pine Brook LLC, 19-0310 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Janumet® XR (sitagliptin phosphate / metformin HCl extended-release tablets) 7,326,708
Merck Sharp & Dohme Corp. v. Anchen Pharms., Inc., 19-0311 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Janumet® XR (sitagliptin phosphate / metformin HCl extended-release tablets) 7,326,708
Merck Sharp & Dohme Corp. v. Sandoz Inc., 19-0312 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Janumet® XR (sitagliptin phosphate / metformin HCl extended-release tablets)

Januvia® (sitagliptin phosphate)

7,326,708
Merck Sharp & Dohme Corp. v. Apotex Inc., 19-0313 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Janumet® XR (sitagliptin phosphate / metformin HCl extended-release tablets)

Januvia® (sitagliptin phosphate)

Janumet® (sitagliptin phosphate / metformin HCl)
7,326,708
Merck Sharp & Dohme Corp. v. Zydus Pharms. (USA) Inc., 19-0314 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Janumet® XR (sitagliptin phosphate / metformin HCl extended-release tablets)

Januvia® (sitagliptin phosphate)

Janumet® (sitagliptin phosphate / metformin HCl)
7,326,708
Merck Sharp & Dohme Corp. v. Mylan Pharms. Inc., 19-0315 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Januvia® (sitagliptin phosphate) 7,326,708
8,414,921
Merck Sharp & Dohme Corp. v. Macleods Pharms. Ltd., 19-0316 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Januvia® (sitagliptin phosphate)

Janumet® (sitagliptin phosphate / metformin HCl)
7,326,708
Merck Sharp & Dohme Corp. v. Watson Labs., Inc., 19-0317 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Januvia® (sitagliptin phosphate) 7,326,708
8,414,921
Merck Sharp & Dohme Corp. v. Teva Pharms. USA, Inc., 19-0318 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Janumet® XR (sitagliptin phosphate / metformin HCl extended-release tablets)

Januvia® (sitagliptin phosphate)

Janumet® (sitagliptin phosphate / metformin HCl)

Juvisync® (simvastatin/ sitagliptin phosphate)
7,326,708
Merck Sharp & Dohme Corp. v. Sun Pharma Global FZE, 19-0319 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Janumet® XR (sitagliptin phosphate / metformin HCl extended-release tablets)

Januvia® (sitagliptin phosphate)

Janumet® (sitagliptin phosphate / metformin HCl)
7,326,708
8,414,921
Merck Sharp & Dohme Corp. v. Torrent Pharms. Ltd., 19-0320 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Januvia® (sitagliptin phosphate) 7,326,708
Merck Sharp & Dohme Corp. v. Wockhardt Bio AG, 19-0321 (D. Del.) Feb. 13, 2019 Hon. Richard G. Andrews Januvia® (sitagliptin phosphate)

Janumet® (sitagliptin phosphate / metformin HCl)
7,326,708
Genentech, Inc. v. Torrent Pharms. Ltd., 19-0324 (D. Del.) Feb. 14, 2019 Hon. Richard G. Andrews Esbriet® (pirfenidone tablets) 8,383,150
8,778,947
Celgene Corp. v. Hetero Labs Ltd., 19-5797 (D.N.J.) Feb. 14, 2019 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 10,093,647
10,093,648
10,093,649
Celgene Corp. v. Aurobindo Pharma Ltd., 19-5799 (D.N.J.) Feb. 14, 2019 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 10,093,647
10,093,648
10,093,649
Celgene Corp. v. Mylan Pharms. Inc., 19-5802 (D.N.J.) Feb. 14, 2019 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 10,093,647
10,093,648
10,093,649
Celgene Corp. v. Breckenridge Pharm., Inc., 19-5804 (D.N.J.) Feb. 14, 2019 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 10,093,647
10,093,648
10,093,649
Celgene Corp. v. Apotex Inc., 19-5806 (D.N.J.) Feb. 14, 2019 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 10,093,647
10,093,648
10,093,649
Valeant Pharms. North America LLC v. Apotex Inc., 19-5939 (D.N.J.) Feb. 15, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Biogen Int’l GmbH v. Zydus Pharms. (USA) Inc., 19-5987 (D.N.J.) Feb. 15, 2019 Hon. Brian R. Martinotti Tecfidera® (dimethyl fumarate delayed-release capsules) 7,619,001
Merck Sharp & Dohme Corp. v. Lupin Ltd., 19-0347 (D. Del.) Feb. 19, 2019 Hon. Richard G. Andrews Janumet® (sitagliptin phosphate / metformin HCl) 7,326,708
Galderma Labs. L.P. v. Teva Pharms. USA, Inc., 19-0351 (D. Del.) Feb. 19, 2019 Hon. Richard G. Andrews Soolantra® (ivermectin cream) 10,206,939
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000685 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,211,253
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000686 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,211,253
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000687 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,211,253
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000688 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,468,747
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000689 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,468,747
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000690 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,468,747
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000691 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,561,177
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000692 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,561,177
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000693 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,561,177
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000694 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,629,965
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000695 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,629,965
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000696 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,629,965
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000697 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,775,838
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000698 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,775,838
Nalox-1 Pharms., LLC v. Opiant Pharms., Inc., IPR2019-000699 (PTAB) Feb. 19, 2019 N/A Narcan® (naloxone HCl nasal spray) 9,775,838
Celgene Corp. v. Apotex Inc., 19-6999 (D.N.J.) Feb. 26, 2019 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,189,740
8,404,717
9,056,120
Mitsubishi Tanabe Pharma Corp. v. Lupin Ltd., 19-7165 (D.N.J.) Feb. 27, 2019 Hon. Peter G. Sheridan Invokamet XR® (canagliflozin / metformin HCl extended-release tablets) 7,943,582
8,513,202
Valeant Pharms. North America LLC v. Macleods Pharms. Ltd., 19-7296 (D.N.J.) Feb. 28, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Pharmacyclics LLC v. Alvogen Pine Brook LLC, 19-0434 (D. Del.) Mar. 1, 2019 Hon. Colm F. Connolly Imbruvica® (ibrutinib capsules) 7,514,444
8,008,309
8,476,284
8,497,277
8,697,711
8,735,403
8,754,090
8,754,091
8,952,015
8,957,079
9,181,257
9,296,753
9,655,857
9,725,455
10,010,507
10,106,548
10,125,140
Endo Pharms. Inc. v. Perrigo UK Finco Ltd., 19-0437 (D. Del.) Mar. 1, 2019 Hon. Maryellen Noreika Nascobal® (cyanocobalamin nasal spray) 7,229,636
7,404,489
7,879,349
8,003,353
8,940,714
9,415,007
Cipla Ltd. v. AstraZeneca AB, 19-0438 (D. Del.) Mar. 1, 2019 Hon. Maryellen Noreika Nexium® (esomeprazole magnesium delayed-release oral suspension) 6,428,810
Galderma Labs., L.P. v. Amneal Pharms. LLC, 19-0440 (D. Del.) Mar. 1, 2019 Hon. Leonard P. Stark Oracea® (doxycycline capsules) 10,058,564
Biodelivery Sciences Int’l, Inc. v. Chemo Research, S.L., 19-0444 (D. Del.) Mar. 1, 2019 Hon. Colm F. Connolly Belbuca® (buprenorphine buccal film) 8,147,866
9,655,843
9,901,539
Sun Pharm. Indus. Ltd. v. Vistapharm, Inc., 19-7536 (D.N.J.) Mar. 1, 2019 Hon. Stanley R. Chesler Riomet® (metformin HCl oral solution) 6,890,957
Apicore US LLC v. Beloteca, Inc., 19-0077 (E.D. Tex.) Mar. 4, 2019 Hon. Rodney Gilstrap Isosulfan blue for injection 8,969,616
9,353,050
Sawai USA, Inc. v. Biogen MA, Inc., IPR2019-00789 (PTAB) Mar. 4, 2019 N/A Tecfidera® (dimethyl fumarate delayed-release capsules) 8,399,514
Millennium Pharms., Inc. v. Aurobindo Pharma USA Inc., 19-0471 (D. Del.) Mar. 6, 2019 Hon. Colm F. Connolly Velcade® (bortezomib for injection) 6,713,446
6,958,319
UCB, Inc. v. Actavis Labs. UT, Inc., 19-0474 (D. Del.) Mar. 6, 2019 Hon. Leonard P. Stark Neupro® (rotigotine transdermal system) 10,130,589
Valeant Pharms. North America LLC v. Slayback Pharma, LLC, 19-8218 (D.N.J.) Mar. 8, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Valeant Pharms. North America LLC v. Mylan Pharms. Inc., 19-8233 (D.N.J.) Mar. 8, 2019 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Valeant Pharms. North America LLC v. Mylan Pharms. Inc., 19-0037 (N.D.W.V.) Mar. 11, 2019 Hon. Thomas S. Kleeh Jublia® (efinaconazole topical solution) 10,105,444
Pfizer Inc. v. Ajanta Pharma Ltd., 19-0517 (D. Del.) Mar. 15, 2019 Hon. Leonard P. Stark Xeljanz® (tofacitinib tablets) 6,965,027
RE41,783
Biodelivery Sciences Int’l, Inc. v. Chemo Research, S.L., 19-8660 (D.N.J.) Mar. 15, 2019 Hon. Kevin McNulty Belbuca® (buprenorphine buccal film) 8,147,866
9,655,843
9,901,539
Keryx Biopharmaceuticals, Inc. v. Mylan Pharms. Inc., 19-0040 (N.D.W.V.) Mar. 15, 2019 Hon. Thomas S. Kleeh Auryxia® (ferric citrate tablets) 5,753,706
7,767,851
8,093,423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,328,133
9,387,191
9,757,416
Celgene Corp. v. Teva Pharms. USA, Inc., 19-8758 (D.N.J.) Mar. 19, 2019 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 10,093,647
10,093,648
10,093,649
Mayne Pharma Int’l Pty Ltd. v. Prinston Pharm. Inc., 19-0549 (D. Del.) Mar. 21, 2019 Hon. Richard G. Andrews Doryx® MPC (doxycycline hyclate delayed-release tablets) 9,295,652
9,446,057
9,511,031
Sandoz Inc. v. Pharmacyclics LLC, IPR2019-00865 (PTAB) Mar. 21, 2019 N/A Imbruvica® (ibrutinib tablets)

Imbruvica® (ibrutinib capsules)
9,795,604
Mallinckrodt Hospital Products IP Ltd. v. Altan Pharma Ltd., 19-0552 (D. Del.) Mar. 22, 2019 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection) 9,399,012
9,610,265
9,987,238
6,992,218
Vanda Pharms. Inc. v. Teva Pharms. USA, Inc., 19-0560 (D. Del.) Mar. 22, 2019 Hon. Colm F. Connolly Hetlioz® (tasimelteon capsules) 10,149,829
Indivior Inc. v. Aveva Drug Delivery Systems, Inc., 19-60757 (S.D. Fla.) Mar. 22, 2019 Hon. Beth Bloom Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 8,017,150
8,603,514
9,687,454
9,931,305
Boehringer Ingelheim Pharma GmbH & Co. KG v. Aurobindo Pharma Ltd., 19-8840 (D.N.J.) Mar. 22, 2019 Hon. Brian R. Martinotti Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Eli Lilly and Co. v. Dr. Reddy’s Labs., Ltd., 19-1246 (S.D. Ind.) Mar. 27, 2019 Hon. Jane Magnus-Stinson Alimta® (pemetrexed for injection) 7,772,209
Eagle Pharms., Inc. v. Accord Healthcare, Inc., 19-0344 (M.D.N.C.) Mar. 27, 2019 Hon. William L. Osteen, Jr. Argatroban Injections 7,589,106
7,687,516
Eagle Pharms., Inc. v. Accord Healthcare, Inc., 19-9031 (D.N.J.) Mar. 27, 2019 Hon. Claire C. Cecchi Argatroban Injections 7,589,106
7,687,516

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.